Atherosclerosis Plaque Reduction by Lycopene Is Mediated by Increased Energy Expenditure through AMPK and PPARα in ApoE KO Mice Fed with a High Fat Diet.
AMP-Activated Protein Kinases
/ metabolism
Animals
Antioxidants
/ metabolism
Apolipoproteins E
/ genetics
Atherosclerosis
/ metabolism
Carotid Intima-Media Thickness
Diet, High-Fat
/ adverse effects
Energy Metabolism
Humans
Lycopene
/ pharmacology
Mice
Mice, Inbred C57BL
Mice, Knockout
PPAR alpha
/ metabolism
Plaque, Atherosclerotic
/ metabolism
PPARα
atherosclerosis
lycopene
nutraceuticals
oxidative stress
Journal
Biomolecules
ISSN: 2218-273X
Titre abrégé: Biomolecules
Pays: Switzerland
ID NLM: 101596414
Informations de publication
Date de publication:
12 07 2022
12 07 2022
Historique:
received:
28
04
2022
revised:
06
07
2022
accepted:
08
07
2022
entrez:
27
7
2022
pubmed:
28
7
2022
medline:
29
7
2022
Statut:
epublish
Résumé
Lycopene is a carotenoid found in tomatoes that has potent antioxidant activity. The Mediterranean diet is particularly rich in lycopene, which has well-known beneficial effects on cardiovascular health. We tested the effects of lycopene extract in a group of 20 ApoE knockout mice, fed with a high fat western diet for 14 weeks. Starting from week 3 and up to week 14, the mice were randomly divided into two groups that received lycopene (n = 10) by oral suspension every day at the human equivalent dose of 60 mg/day (0.246 mg/mouse/day), or the vehicle solution (n = 10). The lycopene administration reduced triglycerides and cholesterol blood levels starting from week 6 and continuing through to the end of the experiment (p < 0.001). This reduction was mediated by an enhanced liver expression of PPAR-α and AMPK-α and reduced SREBP levels (p < 0.0001). As a histological red-out, the extent of atherosclerotic plaques and the intima−media thickness in the aorta were significantly reduced by lycopene. In this context, lycopene augmented the Nrf-2 positivity staining in the endothelium, thereby confirming that its antioxidant activity was mediated by this nuclear factor. The positive results obtained in this pre-clinical model further support the use of lycopene extracts to reduce atherosclerosis.
Identifiants
pubmed: 35883529
pii: biom12070973
doi: 10.3390/biom12070973
pmc: PMC9313394
pii:
doi:
Substances chimiques
Antioxidants
0
Apolipoproteins E
0
PPAR alpha
0
AMP-Activated Protein Kinases
EC 2.7.11.31
Lycopene
SB0N2N0WV6
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Références
Cell Metab. 2009 Apr;9(4):327-38
pubmed: 19356714
J Nutr. 2011 May;141(5):863-9
pubmed: 21411607
Methods Mol Biol. 2003;209:293-309
pubmed: 12357958
Maturitas. 2011 Apr;68(4):299-310
pubmed: 21163596
Mol Cell. 2007 Oct 12;28(1):91-106
pubmed: 17936707
Curr Opin Lipidol. 2015 Oct;26(5):357-61
pubmed: 26218415
Biochem Biophys Res Commun. 1997 Apr 28;233(3):658-62
pubmed: 9168909
Am Heart J. 2002 Mar;143(3):467-74
pubmed: 11868053
Sci China Life Sci. 2018 Oct;61(10):1212-1221
pubmed: 29656339
J Biol Regul Homeost Agents. 2011 Jul-Sep;25(3):435-41
pubmed: 22023768
Proc Nutr Soc. 2017 May;76(2):122-129
pubmed: 27609297
Biomolecules. 2018 Aug 23;8(3):
pubmed: 30142970
Crit Rev Food Sci Nutr. 2016 Aug 17;56(11):1868-79
pubmed: 25675359
Biochim Biophys Acta. 2010 Aug;1804(8):1652-7
pubmed: 19962456
Clin Sci (Lond). 2018 Jun 21;132(12):1243-1252
pubmed: 29930142
Biomedicines. 2020 Jun 17;8(6):
pubmed: 32560286
Curr Pharm Des. 2017;23(8):1216-1227
pubmed: 28034355
Clin Exp Pharmacol Physiol. 2015 Jun;42(6):632-9
pubmed: 25932745
Curr Opin Lipidol. 2009 Apr;20(2):98-105
pubmed: 19276888
Front Pharmacol. 2018 May 23;9:521
pubmed: 29875663
Proc Natl Acad Sci U S A. 2008 Jul 15;105(28):9793-8
pubmed: 18599449
Front Pharmacol. 2018 May 29;9:506
pubmed: 29896101
Oxid Med Cell Longev. 2017;2017:6341671
pubmed: 29379585
Eur J Pharmacol. 2008 May 31;586(1-3):275-82
pubmed: 18439578
Br J Pharmacol. 2018 Feb;175(4):644-655
pubmed: 29178246
Eur J Nutr. 2003 Aug;42(4):201-6
pubmed: 12923651
PLoS One. 2012;7(1):e30808
pubmed: 22295112
Exp Biol Med (Maywood). 2002 Nov;227(10):908-13
pubmed: 12424333
Molecules. 2018 May 14;23(5):
pubmed: 29757945
Arch Cardiovasc Dis. 2016 Dec;109(12):708-715
pubmed: 27595467
J Agric Food Chem. 2021 Sep 8;69(35):10114-10120
pubmed: 34428895
Free Radic Biol Med. 2011 Sep 1;51(5):978-92
pubmed: 21627987
Nutrition. 2008 Oct;24(10):1030-8
pubmed: 18585898
Exp Biol Med (Maywood). 2002 Nov;227(10):920-3
pubmed: 12424335
Nutrition. 2006 Mar;22(3):259-65
pubmed: 16413753
Br J Pharmacol. 2010 Aug;160(7):1573-6
pubmed: 20649560
Cardiovasc Drugs Ther. 2015 Aug;29(4):319-27
pubmed: 26006701
Neuromolecular Med. 2015 Jun;17(2):192-201
pubmed: 25893744
PLoS One. 2013 May 21;8(5):e64107
pubmed: 23700460
Cureus. 2020 Jul 23;12(7):e9349
pubmed: 32742886
Nutrients. 2020 Apr 26;12(5):
pubmed: 32357526
J Biol Chem. 2008 Jul 18;283(29):20015-26
pubmed: 18482975